Active	Status	Sponsor type	Region	Phase	Filter
7 Active 1 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lau, Christine
NCT04739618: Metastatic Solid Cancer Clinical Trial	Active, not recruiting	2	32	US	Keytruda Injectable Product, pembrolizumab, Yervoy Injectable Product, ipilimumab, GM-CSF, sargramostim, Non-ablative Cryosurgical freezing	ImmunSYS, LLC	Metastatic Cancer	12/24	12/24
NCT04606069: Treat COVID-19 Patients With Regadenoson	Completed	1/2	5	US	Regadenoson, LEXISCAN,, Placebo Control, Saline	University of Maryland, Baltimore	COVID-19, Lung Inflammation	04/23	04/23
NCT04521569: Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System	Completed	1	47	US	Regadenoson, Lexiscan, Placebo, Steen solution	University of Maryland, Baltimore, National Heart, Lung, and Blood Institute (NHLBI)	Lung Transplant	06/24	07/24
NCT06173843: Occupational Exposures Among Firefighters	Recruiting	N/A	2000	US	PFAS / heavy metal testing, exposures	Vincere Cancer Center	Cancer	12/28	12/29
REFLECTION, NCT05205967: A Clinical Practice Learning Program for Galleri®	Recruiting	N/A	17000	US	MCED, SOC	GRAIL, LLC	Early Detection of Cancer, Cancer	06/25	08/26
NCT05780957: Multi-Cancer Early Detection (MCED) of Firefighters	Recruiting	N/A	2000	US	MCED	Vincere Cancer Center, Elypta	Cancer	12/24	12/30
NCT05954299: Vincere Biobank Research Protocol	Recruiting	N/A	5000	US		Vincere Cancer Center	Cancer	12/33	12/38